NCT04858204View on ClinicalTrials.gov

Real Life Second-Line Nivolumab in Advanced Non-Small Cell Lung Cancer

CompletedOBSERVATIONAL
Enrollment

259

Participants

Timeline

Start Date

April 14, 2017

Primary Completion Date

October 31, 2017

Study Completion Date

November 1, 2017

Conditions
NSCLC
Trial Locations (7)

22000

Centre Hospitalier Yves Le Foll, Saint-Brieuc

22101

CH DINAN, Dinan

29609

CHRU de Brest, Brest

35000

CHU de Rennes, Rennes

56017

CH de VANNES, Vannes

56100

Centre Hospitalier de Bretagne Sud, Lorient

Unknown

Centre hospitalier de Saint Malo, St-Malo

All Listed Sponsors
lead

University Hospital, Brest

OTHER

NCT04858204 - Real Life Second-Line Nivolumab in Advanced Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter